Matt Stangis the founder of Delic Corp, the first Psychedelic Wellness company.
Early studies find psilocybin shows promise for some psychiatric disorders...
With numerous studies in stage 3 trials, the opportunities to leverage psilocybin for clinical care is likely to expand in the next few years. Matt Stang shares his excitement for the future of this agent as means to help more patients.
